Health ❯ Clinical Research

Drug Trials

Patient Outcomes Animal Studies Polypill Studies Omalizumab Drug Trials Omalizumab (Xolair) Trials Adverse Effects Antibiotic Efficacy Mouse Models Laboratory Studies Neurodevelopmental Disorders Phase 1 Trials Human Studies Phase 3 Trials Anti-Amyloid Therapies Efficacy Studies Cannabis Studies Participant Enrollment Adjuvant Therapy Phase II Studies Regulatory Approval GLP-1 Agonists

Biogen, Dayra Launch $50 Million Pact to Develop Oral Macrocyclic Peptides for Immunology

The early-stage tie-up links Dayra’s macrocycle platform to Biogen’s development engine to expand its immunology pipeline.

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

Bristol Myers’ Iberdomide Combo Hits MRD Goal in Phase 3 Myeloma Study

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

UCLA Study Finds Antidepressants Boost Immune Response Against Cancer